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Locally Excited State – Charge Transfer State Coupled Dyes as 
Optically Responsive Neuron Firing Probes       
Dumitru Sirbu,[a] John B. Butcher,[b] Paul G. Waddell,[c] Peter Andras,[b] and Andrew C. Benniston[a] 
 
Abstract: A selection of NIR-optically responsive neuron probes were 
produced comprising of a donor julolidyl group connected to a 
BODIPY core and several different styryl and vinylpyridinyl derived 
acceptor moieties. The strength of the donor-acceptor interaction was 
systematically modulated by altering the electron withdrawing nature 
of the aryl unit. The fluorescence quantum yield was observed to 
decrease as the electron withdrawing effect of the aryl subunit 
increased in line with changes of the Hammett parameter. The 
effectiveness of these fluorophores as optically responsive dyes for 
neuronal imaging was assessed by measuring the toxicity and signal-
to-noise ratio (SNR) of each dye. A great improvement of SNR was 
obtained when compared to the first-generation BODIPY-based VSDs 
with concomitant toxicity decrease. The mechanism for the optical 
response is disparate from conventional cyanine-based dyes opening 
up a new way to produce effective voltage sensitive dyes that respond 
well into the NIR region. 
Introduction 
Multifunctional dyes with a push-pull architecture are often 
associated with various interesting physical properties such as 
strong charge-transfer (CT) character,[1] large dipole moments in 
the ground and excited state,[2] non-linear optical (NLO) 
behaviour,[3] solvatochromism[4] and long-range electron 
transfer.[5] In this context, boron dipyrromethene (BODIPY) based 
dyes have proven to be exceptionally beneficial due to their highly 
adaptable photophysical properties.[6] Bespoke BODIPY 
molecules exhibiting CT character have been proposed as 
candidates for various applications such as fluorescence probes 
(in solution and living tissues) and visible light harvesting.[7] We 
have been especially interested in new dyes with CT character for 
application as optically responsive voltage sensitive dyes (VSDs) 
for neural imaging. Within the field of VSDs, zwitterionic dyes such 
as di-4-ANEPPS[8] are most commonly used but are far from 
perfect. VSDs are an alternative technology within the field of 
neuronal imaging providing superior time-resolution when 
compared to Ca2+ responsive dyes, but suffer from an inferior 
signal-to-noise (SNR) ratio that is roughly 10 times less than that 
offered by most Ca2+ dyes. The ultimate aim, therefore, is to try 
and improve the responsivity of VSDs in terms of SNR while 
maintaining their fast time-resolution and keeping their toxicity low. 
In the search for new superior VSDs our attention turned to 
BODIPY derivatives which displayed strong CT character and 
were emissive from a locally excited state (LES). The premise 
was that CT within the molecular framework would respond to 
electric field changes and perturb mixing with the LES. The optical 
response would therefore not follow the conventional Stark Effect 
approach of most VSDs which rely on direct charge transfer 
emission that is often weak.  
Scheme 1. Reagents and Conditions: (i) CH3CN, molecular sieves, piperidine, 
acetic acid, yields: JULBD1 70%, JULBD2 44%, JULBD3 13%, JULBD4 10%, 
JULBD5 49 %; (ii) CH3CN, MeI, KPF6, yield JULBD6 75%. Note: selected 
numbering of the dipyrromethene unit is also shown. JULBD1, R = Ph; JULBD2, 
R = p-PhCO2H; JULBD3, R = p-PhCN; JULBD4, R = p-PhNO2; JULBD5, R = 
p-Py; JULBD6, R = N-Me p-Py. 
 
Our first rudimentary model dyad system, based on a julolidyl 
donor linked to an unsubstituted BF2-dipyrromethene subunit, 
showed exceptionally strong CT character.[7e] The charge density 
distribution within the dyad was evident by a solvent effect, and 
13C NMR chemical shifts could be fitted adequately to a polarity 
model.[7d] Although the electrical firing of neurons in crab 
stomatogastric ganglions (STG) could be monitored by a 
fluorescence intensity modulation, the changes were still rather 
modest. In an attempt to enhance this effect we present a series 
of new BODIPY dyes incorporating the julolidyl donor unit that 
gives rise to a very pronounced charge-transfer absorption in the 
red region. The introduction of the styryl unit strongly affects the 
S0→S1 electronic transition so that HOMO and HOMO-1 for 
JULBD1 are very close in energy, as revealed by electronic 
absorption spectroscopy and DFT molecular modelling 
calculations. The introduction of electron withdrawing groups 
allowed for fine-tuning of the molecule’s photophysical properties 
that results in significant SNR enhancement as compared to the 
first generation of BODIPY based VSDs. The best dye, JULBD6, 
is on par with the benchmark cyanine-based di-4-ANEPPS VSD 
but is responsive into the NIR. 
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Results and Discussion 
Synthesis 
 
The design of the new dyes is based on -extension of the 3,5 
positions of the BODIPY subunit which is well documented in the 
literature.[9] Compounds JULBD1-5 were synthesised by a 
modified literature procedure,[10] which employed an acid/base 
catalysed condensation of an aldehyde with the dimethyl-BODIPY 
1. Reactions were easily monitored due to the colour change from 
purple to deep blue as the starting material was consumed. While 
the usual purification procedure for a product from a BODIPY 
condensation reaction involves extensive column 
chromatography to separate the mono-functionalised product, it 
should be noted that compounds JULBD1 and JULBD2 were 
obtained using chromatography-free purification procedures in 
relatively high yields. The other three compounds JULBD3-5 did 
require careful silica gel column chromatography and this is one 
reason for their low yields. JULBD6 was obtained in a good yield 
by methylation of JULBD5 with MeI in CH3CN and precipitation 
with aqueous KPF6.  
 
All compounds were characterized by high-field NMR 
spectroscopy including 1H, 13C, 11B and 19F nuclei (see Supporting 
Information). The unequivocal identification of two doublets with 
high J coupling constants (16.2–16.4 Hz) for JULBD1 and 
JULBD3-6 are consistent with all-trans double bonds from the 
condensation reaction. An exception is the carboxylic acid 
substituted derivative JULBD2 which displayed a broad singlet at 
7.69 ppm, which would suggest that there is accidental 
equivalence of the proton signals. The triplet (J = 31 – 33 Hz) in 
11B NMR spectra and the quartet in the 19F NMR spectra (J = 31 
– 33 Hz) are typical for BF2 complexes, and together with mass 
spectrometry results (see Supporting Information) corroborated 
the proposed structures. The additional doublet at -70.1 ppm (J = 
711 Hz), found in the 19F NMR spectrum of JULBD6 is consistent 
with the PF6- anions. The positive ion mass spectra of JULBD1, 
JULBD3 and JULBD4 consisted of a mixture of [M]+ and [M+H]+ 
molecular ion patterns, while the compound JULBD5 showed 
only the [M+H]+ ion. The negative ion mass spectrum of JULBD2 
showed the [M–H]– ion typical for a carboxylic derivative. The [M-
F]+, [2M+H]+ ions in the positive mode and [M–2H]2–, [M-2H+Na]–  
ions in the negative mode MS were also identified. The positive 
ion mass spectrum of JULBD6 consisted of the [M-PF6]+ and [M-
2PF6]2+ cations. 
 
X-ray Crystallography 
As further characterization of the compounds, crystals suitable for 
analysis by single-crystal X-ray diffraction could be grown for two 
of the derivatives. The structures of JULBD3 and JULBD4 
unequivocally confirm their identity. Both compounds crystallise 
in the centrosymmetric, triclinic space group P-1 as solvates with 
CH2Cl2 and CHCl3 in the case of JULBD3 and JULBD4, 
respectively. The solvent molecules in both structures have been 
modelled as disordered over multiple sites. The molecular 
structure of JULBD3 is illustrated in Figure 1, and selected bond 
lengths and angles are shown in Table 1. The two trans C=C 
bonds are confirmed by the X-ray analysis and, as observed in 
previous structures, the julolidyl subunit is twisted with respect to 
the dipyrromethene core (torsion angle C10-C8-C29-C30 = 
43.7(2)°). It is noted that the two propyl moieties of the julolidyl 
group are in an anti-arrangement (Figure 1B) and form a chair-
like conformation.  
Figure 1. X-ray crystal structure of JULBD3 (A), an orientation highlighting the 
conformation of the julolidyl moiety (B), and another illustrating the twisting of 
the julolidyl and out-of-plane nature of the alkenyl-aryl groups (C). All 
displacement ellipsoids are drawn at the 50% probability level. Hydrogen atoms 
and the CH2Cl2 solvent molecules are omitted for clarity.
 Table 1. Selected bond lengths and angles for JULBD3 and JULBD4. 
Atoms Bond Length/ Å Atoms Bond Angle/ o Atoms Bond Length / Å Atoms Bond Angle / o 
JULBD3 JULBD4 
B-F 
1.390(2),1.395(2) 
1.340[a] 
F1-B4-F2 
108.79(14) 
109.40[a] 
B – F 1.385(2), 1.389(2), 
1.399a 
F1 – B4 – F2 109.43(15) 
109.47a 
N-B 
1.547(2), 1.543(2) 
1.554[a] 
N2-B4-N1 
106.82(13) 
106.86[a] 
N – B 1.553(2), 1.552(2) 
1.554a 
N2 – B4 – N1 106.63(14) 
106.82a 
C=Ctrans 
1.340(3), 1.338(3) 
1.350[a] 
N4-C28-C25 
177.6(2) 
179.9[a] 
C = Ctrans 1.342(3), 1.339(3) 
1.351a 
O2 – N3 – O1 123.47(16) 
124.70a 
C≡N 1.143(3), 1.147(2) 
1.157[a] 
N3-C19-C16 
178.5(2) 
179.9[a] 
   N = O 1.235(2), 1.223(2), 
1.231(2), 1.229(2) 
1.221a 
O4 – N4 – O3 122.82(17) 
124.70a 
N5–C32 1.372(2) 
1.373[a] 
C10-C8-
C29-C30 
43.7(2) 
49.1[a] 
N5–C30 1.376(2) 
1.380a 
C9-C8-C27-C32 47.1(2) 
49.3a 
[a] Values calculated using DFT (B3PW91) and the 6-311+G(d, p) basis set in the gas phase. 
    
 
 
 
 
 
The front view (Figure 1C) clearly shows that the two cyano-styryl 
subunits are slightly out-of-plane with respect to the BODIPY 
core; angles between planes created using the BODIPY subunit 
and each aryl ring are ca. 6.3o and 21.7o. Evidently the bend is 
more pronounced on the right-hand side of the diagram. The 
crystal packing diagram (see Supporting Information) reveals that 
the molecular units pack in a head-to-tail arrangement along the 
b-axis; the N5-F2 separation distance between adjacent groups 
is 4.149(2) Å. When viewed along the a-axis, a similar head-to-
tail arrangement is also observed in the CH2Cl2 molecules located 
between the planes. 
 
The molecular structure for JULBD4 is illustrated in Supporting 
Information along with selected bond lengths and angles. A 
noteworthy point is the location of the CHCl3 molecule, which sits 
in a cleft between the two nitro-styryl arms. The julolidyl subunit is 
again found to be twisted with respect to the dipyrromethene core 
though slightly greater than seen in JULBD3.  
 
Absorption and Fluorescence Spectroscopies  
Room temperature electronic absorption spectra for JULBD1-6 in 
DMSO are shown in Figure 2 with relevant parameters presented 
in Table 2. The spectrum for JULBD1 shows strongly red-shifted 
BODIPY patterns and comprises a band on the edge of the near-
UV region at max = 349 nm, and a strong band in the red region 
at max = 630 nm with a vibrational shoulder on the high-energy 
side. In addition, a broad profile is observed in the red / near-IR 
border which is attributed to the charge-transfer absorption.  
 
Figure 2. UV-Vis-NIR absorption spectra for compounds JULBD1-6 in DMSO: 
experimental values (a) and DFT calculated (b) using IEF-PCM solvent model 
at B3PW91/6-311+G(d,p) theoretical level.  
 
 
 
 
Deconvolution of the absorption spectrum into a series of 
Gaussian bands (see Supporting Information) shows that the 
introduction of styryl units to JULBD1 strongly shifts the S0S1 
electronic transition by 144 nm, but the CT band remains mostly 
unaffected, as compared to the parent unsubstituted julolidyl 
BODIPY.[7d] The simple explanation is that extending the 
conjugation raises the energy of the BODIPY centred HOMO-1 
whilst the julolidine centred HOMO is not affected, thus the 
redshift in absorption maximum is more pronounced for the 
BODIPY transition HOMO-1LUMO. It should be mentioned that 
the use of a julolidyl unit gives a stronger bathochromic shift 
compared to dimethylamino analogues.[11] The absorption 
spectrum for JULBD2 when compared to JULBD1 shows an 
additional bathochromic shift of the main transition to max = 644 
nm, and an additional broadening of the absorption profile due to 
the CT band (see Supporting Information). A similar broadening 
of BODIPY absorption profile was recently reported6e and also 
attributed to overlap of π–π* and CT transfer transitions. The CT 
character increases when pyridyl and pyridinium substituents are 
introduced with this effect being most pronounced for the latter. A 
general bathochromic shift trend in the absorption profile is 
observed when electron withdrawing groups are introduced by 
increasing the push-pull character of the dyes. The CT-based 
absorption band becomes more evident in the JULBD3–JULBD6 
series, and is red-shifted to 741 nm (see Supporting Information). 
A plot of CT transition energy versus the Hammett constant[12] for 
each substituent is rather tenuous (see Supporting Information). 
 
Table 2. Room temperature UV-Vis-NIR absorption and emission 
parameters for JULB1-6 in dimethylsulfoxide (DMSO). 
Compound ABS 
/ nm
ABS[a] 
/ nm 
EM 
/ nm 
Stokes 
Shift / 
cm-1 
FLU[b] 
/ % 
JULBD1 349, 580sh, 
630, 690sh 
572,594, 
614,[c] 628 
653, 
710sh 
559 
610[d] 
21±0.1 
JULBD2 362,590sh, 
641 
556,596, 
632,[c] 641 
658, 
721 
 
403, 
403[d] 
6±0.1 
JULBD3 
345sh,359, 
590sh,634, 
710sh 
572,596, 
633,642[c] 
660, 
729 
621 
646[d] 
3±0.1 
JULBD4 324,386
br, 
450sh,600sh 
647, 730sh 
567, 603, 
646, 661[c] 
683, 
755 sh 
815 
839[d] 
1.3±0.2 
JULBD5 260, 570sh, 
616, 690sh 
552, 578, 
616, 661[c] 
653, 
696sh, 
732sh 
919 
919[d] 
1.0±0.2 
JULBD6 277, 376, 
433sh, 590sh, 
639, 745sh 
541, 590, 
639, 741[c] 
684, 
760sh 
1030 
1030[d] 
0.4±0.2 
[a] Data obtained by deconvolution of the absorption spectra. [b] Quantum 
yields calculated relative to H2TPP in ethanol under N2 (ΦFLU = 11 %). [c] 
The CT absorption band. [d] The Stokes Shift calculated versus the 
deconvoluted BODIPY absorption band. sh = shoulder, br = broad.  
    
 
 
 
 
 
 
As presented in Table 2 the CT band is higher in energy than the 
BODIPY localised transition for JULBD1 and JULBD2 but their 
positions are interchanged for JULBD3 and the energy difference 
increases to 0.27 eV for JULBD6. For JULBD4 and JULBD6 an 
additional broad absorption feature is observed in the blue region 
of the spectrum that is potentially attributed to mostly HOMO and 
HOMO-1 to LUMO+1 electronic transitions.  
 
The change in the electron withdrawing properties of the vinylaryl-
based fragments are more obvious by inspection of the emission 
spectroscopy results. The room temperature fluorescence 
spectra for JULBD1-6 in DMSO are shown in Figure 3 with 
relevant parameters presented in Table 2. The emission spectrum 
for JULBD1 consists of a main band at 653 nm with a smaller 
broad band on the low-energy side. The emission is gradually red 
shifted to 684 nm and the fluorescence quantum yield drops 
dramatically by 50 fold from 0.21 for JULBD1 to about 0.004 for 
JULBD6. Figure 4 shows the trend for fluorescence quenching 
with the corresponding Hammett factor for each substituent. As 
the electron withdrawing properties of the substituent increase, 
the CT state becomes lower in energy compared to the locally 
excited state, so favouring fluorescence quenching via the 
population of the non-emissive CT state. The fluorescence 
quenching trend with the increase of the driving force for 
intramolecular CT is in agreement with electron transfer occurring 
in the Marcus normal region.[13] The excitation spectra (see 
Supporting Information) show a similar pattern to the electronic 
absorption profiles except the missing CT band, thus proving the 
non-emissive nature of the CT state. The Stokes’ shifts for 
JULBD1-3 are relatively small, but there is an evident increase 
across the JULBD4-6 series to 1030 cm-1 for JULBD6 which 
contains the most pronounced charge-transfer character. All 
compounds were found to be non-fluorescent in the solid state, 
probably because of the short distance between molecules in the 
crystal and the resulting cooperative excited-state quenching. 
Figure 3. Room temperature emission spectra (λex = 580nm) for JULBD1-6 in 
DMSO. 
 
 
Figure 4. Plot of the fluorescence quantum yield versus the Hammett 
substituent constant (circles) and the energy difference of the CT and BODIPY-
based transitions (triangles). 
Molecular Modelling 
In order to understand the nature of the electronic transitions, DFT 
optimized geometries for compounds JULBD1-6 were calculated. 
The frontier molecular orbitals (MO) for JULBD1 and JULBD6 are 
presented in Figure 5 and the diagram of MO energies is 
presented in Supporting Information. The HOMO-1 is localised on 
the vinylaryl-BODIPY unit and the HOMO is predominantly 
localised on the julolidyl moiety. The LUMO is associated with the 
vinylaryl-BODIPY core so, very crudely, the HOMOLUMO 
electronic transition represents julolidyl to vinylaryl-BODIPY 
charge transfer. The calculated HOMO-1LUMO gap for 
JULBD1 is 2.31 eV, while the predicted HOMOLUMO gap is 
2.15 eV, and hence the two bands should overlap (ΔE = 0.16 eV).  
 
Calculation results performed on the other derivatives revealed 
somewhat similar frontier orbital diagrams (see Supporting 
Information) albeit with disparate energies. A general trend of 
decreasing band gap is observed across the JULBD1-4, 5-6 
series. Switching from phenyl to pyridyl substituents results in a 
drop in LUMO energy and thus the band gap increases. Also, a 
gradual increase of the HOMO–HOMO-1 gap is observed across 
the JULBD1-6 series from 0.16 eV to 0.51 eV, consistent with the 
separation trend of the two electronic transitions in the UV-Vis-
NIR spectra. The LUMO+1 is well separated in energy (> 1 eV) 
from the LUMO for JULBD1-3. Two points are worth noting in the 
case of JULBD4: (i) the LUMO extends well on to the nitro group 
and (ii) LUMO+1 is separated by only 0.48 eV from the LUMO and 
is localised almost exclusively on the nitrostyryl unit, therefore the 
HOMOLUMO+1 transition represents a pronounced julolidyl to 
nitrophenyl charge transfer. For compound JULBD5 the HOMO–
LUMO gap is larger than that of JULBD1, while the HOMO–
HOMO-1 gap is 0.33 eV and increases to 0.51 eV for JULBD6. 
For the latter the LUMO extends well on to the pyridinium cations 
which is consistent with a more pronounced charge-transfer 
character. Once again the LUMO+1 localised on the electron 
withdrawing substituents is closer to the LUMO so one would 
expect the HOMO–LUMO+1 transition to appear in the visible 
region of the spectrum. Interestingly the torsion angle between 
    
 
 
 
 
 
the julolidyl and BODIPY units gradually decreases across the 
JULBD1-6 series and this probably contributes to the greater 
charge transfer character of JULBD6. The Mulliken charge 
distribution within the molecular dyads JULBD1-6 is consistent 
with strong ground-state charge transfer (see Supporting 
Information). The high ground-state dipole moment for the 
optimised structures is oriented along the B–NJUL axis for 
JULBD1-5 and in the opposite direction for JULBD6. 
 
Figure 5. Representation of the Gaussian calculated Kohn-Sham frontier 
molecular orbitals for JULBD1 (left) and JULBD6 (right) in DMSO solvent using 
IEF-PCM model at B3PW91/6-311+G(d,p) theoretical level. 
 
Time-dependent DFT (TD-DFT) calculated electronic absorption 
spectra are shown in Figure 2 with the relevant parameters in 
Supporting Information. A general trend of lower predicted 
energies for CT transitions and higher energies for the BODIPY 
localised transitions is observed when compared with 
experimental data. Although the calculated energy difference 
between BODIPY and CT transitions is larger than for the 
experimental data, the decreasing trend in CT band energy 
relative to the BODIPY transition was well predicted (see 
Supporting Information). Generally the theoretical absorption 
profiles match quite well with the experimental results in relation 
to the shift trends of the bands and the relative position of the 
electronic transitions. It is worth mentioning that the additional 
absorption band in the blue region for compounds JULBD4 and 
JULBD6 is also consistent with the experimental results. While 
the B3PW91 functional exhibited greater consistency of the 
BODIPY transition energy with experimental data, the 
mPW1PW91 functional gave generally better results for CT 
transitions and a smaller energy difference between transitions. 
Thus, the shape of the absorption profile is a better match for the 
experimental observation when the mPW1PW91/6-311+G(d,p) 
theoretical level is employed. 
 
 
 
Neuronal imaging 
The effectiveness of each of the dyes reported here for neuronal 
imaging was assessed using the stomatogastric ganglion (STG) 
of the brown crab Cancer pagurus.  The STG is one of the most 
studied small biological central pattern generator motor systems 
due to the relatively large size, accessibility and robustness of the 
neurons located in the STG.  All 26 neurons within the STG are 
known along with their connectivity. The STG contains the well-
known central pattern generator neuronal network that produces 
a pyloric rhythm (PR) that controls the movement of muscles in 
the foregut of the gastric system of the crab[14] and involves 11 
neurons (1x AB, IC, VD and LP neuron, 2x PD neurons and 5x 
PY neurons) with a typical cycle frequency of ~1-2 Hz.  Optical 
recording of the STG using VSDs has been well-studied,[15] 
allowing the simultaneous recording of the electrical activity of 
many cells.   
Figure 6. Fluorescence images of the STG of C. pagurus after bath application 
of JULBD1 (a) and JULBD2 (b) investigated here. 
For each experiment, the preparation was dissected and the dye 
bath was applied for 20 minutes, followed by a 20-minute washout 
period.  Recording was initiated immediately after the washout 
period was complete.  All of the dyes were applied at 10-4 M with 
the exception of JULBD2 and JULBD5 which were too toxic at 
this concentration (indicated by the lack of extracellular neural 
activity) and therefore applied at 10-5 M. Figure 6 shows an 
example of an STG after BODIPY dyes had been bath applied. 
Comparison of the fluorescence images shows that some of the 
new BOPIDY dyes show good fluorescence properties, in 
particular JULBD1-4 where the dyed neuropil and individual 
neurons can be clearly seen (see Supporting Information). There 
is some staining of the neuropil and cell membranes when using 
JULBD5, but very little fluorescence is achieved when using 
JULBD6. One can relate the decrease of the fluorescence 
staining with the quantum yield decrease in the JULBD1-6 series.  
It should be noted that strong fluorescence signal is not 
necessarily a requirement for VSDs but it is the intensity 
modulation which allows for sensing of membrane potential 
changes. While good fluorescence is useful and indeed desirable 
in order to observe the STG under the microscope, low 
fluorescence may not necessarily result in a poor SNR where, in 
(b) JULBD1 (c) JULBD2 
  
 
  
LUMO (-3.19 eV) LUMO+1 (-1.84 eV) 
 
LUMO (-3.94 eV) LUMO+1 (-3.15 eV) 
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fact, the opposite could be true if the change in fluorescence 
response to neural activity is large compared to the low-level 
baseline fluorescence. 
 
Figure 7. The toxicity of each novel BOPIDY-based dye as measured by a 
change in the PR frequency (Hz) compared with di-4-ANEPPS over a variety of 
fluorescence durations. 
The toxicity of each dye was assessed by calculating the change 
in frequency of the PR measured at the lvn nerve of the 
preparation where one cycle was defined as the duration of 
between the onset of an LP neuron burst and the next LP neuron 
burst, similar to Pruess and Stein.[16] For each dye, the STG was 
illuminated with appropriate light for increments of 20s, starting 
from 20s to 300s and the PR frequency calculated.  As Figure 7 
shows, the toxicity of each dye varies. As di-4-ANEPPS is widely 
used, it is not surprising that it has a suitably low toxicity, as shown 
by the small change in the PR frequency for each light duration 
increment. In comparison, JULBD previously reported by our 
group[7e] soon killed the preparation after 100 seconds of 
fluorescent light exposure, indicated by the lack of PR.  A similar 
effect can be seen with JULBD2 and JULBD5, which cause a 
more pronounced increase in PR frequency prior to the death of 
the preparation, despite lower concentrations of 10-5 M that were 
applied in the case of these two dyes. Figure 7 shows that 
JULBD1,3,4,6  have potentially promising results in terms of 
toxicity, where the PR remains around 1 Hz, similar to that of di-
4-ANEPPS. It can be concluded that the introduction of 
substituents in β-position reduces the toxicity of BODIPY dyes, 
with the exception of JULBD2 and JULBD5. Pyridine and 
carboxylic acid are both strong coordinating units and this could 
be argued to cause their higher toxicity.  
 
 
Figure 8. The SNR of each dye compared with commercial di-4-ANEPPS. 
Equation 1 was used to predict the SNR values. 
Figure 9. Raw (blue) and averaged (black) optical VSD (top) and corresponding 
intracellular recording (bottom) for JULBD6.  The effect of the current injection, 
as indicated by the shaded area, into the recorded cell can be clearly seen in 
the optical data for both VSDs, while the effect on the cell membrane voltage 
can be seen in the bottom plots. 
To further assess the change in fluorescence of the dyes for 
neuronal imaging, the signal-to-noise ratio (SNR) for each dye 
was calculated, again using di-4-ANEPPS as the benchmark.  
These experiments involved the injection of a 0.1 nA current into 
a neuron while excitation light was applied for 32 seconds and the 
fluorescent activity imaged. As shown in the Figure 8, BODIPY 
dyes JULBD1-5 offer only slightly lower SNR values to di-4-
ANEPPS. The superior SNR of JULBD6 is interesting given the 
poor staining. Figure 9 shows a representative example of the 
optical recording and the corresponding intracellular cell 
membrane voltage recording for JULBD6 when injecting a 
    
 
 
 
 
 
chosen cell with 0.1 nA of current. This data shows a clear 
correlation between the optical signal and the intracellular data 
where action potentials match increases in fluorescence in many 
cases, and the current injection results in an increase in the 
membrane voltage potential and the optical signal at very similar 
time-scales. When compared to the first generation of BODIPY 
VSDs,[7e] dyes presented in this work show at least a three-fold 
enhancement of fluorescence imaging performance. This can be 
attributed to a higher sensitivity to membrane potential changes, 
better alignment with the external electric field but also a better 
light penetration in the red region of the spectrum. These results 
indicate that BODIPY dyes are a promising alternative VSD to di-
4-ANEPPS when recording the activity of multiple neurons. 
 
Two possible mechanisms could be considered by which 
neuronal membrane potential changes can result in fluorescence 
signal modulation. Change of the BODIPY and CT transition 
energies from interaction of the dipole moments of the respective 
states with the external electric field can shift the absorption / 
fluorescence spectra out of the filters window, while the change 
in the relative position of the two excited states will affect the 
electron transfer driving force and the fluorescence quantum yield. 
It could be argued that in line with the first pathway, the drop in 
SNR for JULBD5 might be a result of the blue-shifted absorption 
profile as compared to JULBD1-4,6 analogues. The improved 
signal for JULBD6 is possibly also a result of the better dye 
alignment parallel to the membrane potential as result of 
hydrophilic pyridinium cations acting as anchoring groups. What 
is evident is that the voltage sensing by BODIPY dyes occurs 
differently compared to ANEPPS dyes as fluorescence occurs 
from the CT state in the latter, while for JULBD1-6 emission 
occurs primarily from the locally excited BODIPY unit. 
In an attempt to quantify the above mentioned structure-property 
relationships the experimental data were analysed using linear 
regression models. The dependent variable used was the 
calculated average SNR for each dye and the independent 
variables being the fluorescence quantum yield, Φf, ground state 
dipole moment, μGS, BD and CT transitions energy, EBD and ECT, 
or their difference, ΔE. Equation 1 represents a conjectural 
dependence of SNRpred with Φf, μGS, EBD and ΔE. Even though 
there we are not aware of an arguable scientific explanation[17] of 
Eq. 1 it is immediately obvious that the two major component in 
the SNRpred relationship are the transition energy gap and the 
energy of the BD transition. Predicted values are in a good 
agreement with experimental data supporting the validity of the 
model (Figure 8). Setting EBD and ECT as two separate variables, 
or excluding EBD gives less accurate models suggesting that the 
relative position of the CT and BD absorption bands is more 
important compared to the absolute value of the CT transition 
energy.  
𝑺𝑵𝑹𝒑𝒓𝒆𝒅 = 𝟐. 𝟑𝟑𝟐 𝜟𝑬 − 𝟐. 𝟗𝟎𝟔 𝑬𝑩𝑫 + 𝟎. 𝟎𝟕𝟖 𝚽𝐟 + 𝟎. 𝟎𝟕𝟐 𝝁𝑮𝑺 +
𝟔. 𝟓𝟔𝟑          (Eq. 1) 
The general redshift of the spectrum along with a more 
pronounced charge transfer character seems to be the way of 
improving the SNR of the BODIPY voltage-sensing dyes. This 
SNR relationship between the basic photophysics of the 
BODIPYs and their potentiometric response affords for the first 
time a predictive tool for greatly improving VSDs. 
Conclusions 
This work introduces a real viable alternative to the cyanine-based 
voltage sensitive dyes based on the BODIPY subunit. In addition 
the optical response is pushed out to the far-red and near infrared 
region (NIR) which offers advantages over simple VSDs. The 
stomatogastric ganglion of the brown crab (C. pagurus) offers a 
good model to measure both toxicity and change in fluorescence, 
as indicated by the signal to noise ratio, for the new VSDs. The 
toxicity of most dyes is acceptable and comparable to the widely 
used VSD, di-4-ANEPPS, with one exception which disrupts the 
pyloric rhythm of the STG to the point where neural activity no 
longer exists soon after the dye is applied. The majority of dyes 
also offer comparable SNR values as di-4-ANEPPS and show 
similar changes in fluorescence that correlate well with changes 
in neuronal membrane potentials.  Importantly the dyes operate 
under normal voltage alterations that are observed across a real 
membrane.     
 
While the julolidyl unit gives rise to a strongly red-shifted CT 
absorption, the π-extension in the β-position brings the localised 
* and CT electronic transitions closer together in energy. In 
addition, the lack of bulky substituents on the dipyrromethene 
subunit proximal to the julolidyl (i.e., 1,7 positions) is also 
significant in the molecular design. The minimisation of steric 
hindrance permits the julolidyl group to twist to the optimum 
geometry to facilitate through-bond electronic communication. 
The overall molecular design also offers a straightforward 
approach to finely tune the position of the charge transfer state 
relative to the BODIPY S1 state, so that the interplay of the two 
excited states controls the fluorescence of the chromophore, thus 
allowing for sensing of changes in the environment (i.e., electric 
field). The new design shows a substantial improvement 
compared to the first generation BODIPY-based VSDs both in 
terms of SNR and toxicity. These results clearly show the potential 
that BODIPY dyes have for the large-scale imaging of neuronal 
networks.  
 
Future work is involved in the design and preparation of next 
generation BOPIDY-derived VSDs, by DFT-guided tuning of the 
CT and BD excited states energy and application of the 
hypothesised structure-property relationship. The aim is to 
produce enhanced responsive dyes[18] for their use in monitoring 
neuronal activity in STG and, ultimately, mammalian tissue for 
applications such as the study of diseases 
 
    
 
 
 
 
 
Experimental Section 
Structural characterisation 
1H-, 13C- and DEPT-135° NMR spectra, as well as two-dimensional homo- 
(1H/1H COSY-45°) and heteronuclear (1H/13C HMQC and HMBC) 
correlation spectra were recorded with a Jeol ECS 400 MHz and a Bruker 
700 MHz spectrometers. Chemical shifts for 1H- and 13C-NMR spectra are 
referenced relative to the residual protiated solvent. 11B-NMR spectra are 
referenced relative to BF3·OEt2. 19F-NMR spectra are referenced relative 
to CFCl3. Electronic absorption spectra were recorded at RT using a 
Shimadzu UV-1800 spectrophotometer. Fluorescence emission spectra 
were acquired at RT with Shimadzu RF-6000 fluorimeter.  
All crystal structure data were collected on an Xcalibur, Atlas, Gemini Ultra 
diffractometer equipped with an Enhance Ultra (Cu) X-ray Source (λCuKα 
= 1.54184 Å) and an Oxford Cryosystems CryostreamPlus open-flow N2 
cooling device. Cell refinement, data collection and data reduction were 
undertaken via the CrysAlisPro[19] software. Intensities were corrected for 
absorption empirically using spherical harmonics. The structures were 
solved using XT[20] and refined using XL[21] through the Olex2 interface.[22] 
All non-hydrogen atoms were refined with anisotropic displacements and 
hydrogen atoms were positioned with idealised geometry and constrained 
using a riding model. 
Molecular modelling 
In order to estimate the energies of BODIPY based and CT absorptions 
the spectrum profile in the red region was deconvoluted into four peaks 
with the PeakFit software. Three peaks were set to have the same full-
width at half-maximum while the width of the fourth peak modelling the CT 
band was left independent. The fitted CT band was always about four 
times broader than the BODIPY-based transitions.  
Energy-minimised structures of JULBD1-6 were calculated in Gaussian 
09[23] in order to describe and compare the frontier molecular orbitals. 
Firstly, the structure of JULBD3 was optimised with the DFT B3LYP/3-21G 
method and the result was used as the input for calculations at the 
B3LYP/6-311+G(d,p), B3LYP/LanL2DZ, B3PW91/6-311+G(d,p) and 
B3PW91/LanL2DZ theoretical levels without any symmetry constraint in 
the gas phase. The results were compared with the X-ray crystal structures. 
The B3LYP functional returned generally longer B-F and N-B bonds 
compared to B3PW91 and the B3PW91/6-311+G(d,p) optimization 
method was selected for further calculations. The optimised geometries 
were further used as input for calculations in DMSO solvent using IEF-
PCM and the same theoretical level. Energy minimization calculations 
were monitored using the programme Molden and run in parallel with 
frequency calculations to ensure optimized geometries represented local 
minima. The UV-Vis-NIR absorption spectra of compounds JULBD1-6 in 
DMSO were calculated using IEF-PCM solvent model at B3PW91/6-
311+G(d,p) TD-DFT theory level, and their images were obtained by using 
0.1 and 0.2 eV half-widths at half-height for the BODIPY and CT transitions, 
respectively.  
Dissection 
Adult Cancer Pagurus were obtained from Hodgkinson Fresh Fish 
(Smithfield Market, Manchester, UK).  Crabs were housed in tanks with 
artificial sea water at 10-14°C (salt content ~1.025 g/cm3) made from 
artificial sea salt (Reefsalt, AquaMed).  Crabs were dissected according to 
Gutierrez and Grashow,[24] with the STNS pinned down in a silicone 
elastomer-lined (ELASTOSIL RT-601, Wacker, Munich, Germany) Petri 
dish in saline consisting of (mmol/L): NaCl, 440; MgCl2∙6H20, 26; 
CaCl2∙2H20, 13; KCl, 11; trizma base, 10; maleic acid, 5.  The saline was 
kept between 10-15°C and had a pH of 7.2-7.5.  All experiments were 
carried out in accordance with the European Communities Council 
Directive of 25th November 1986 (86/609/EEC). 
Preparation and application of the dyes 
For each of the dyes, a stock solution was created by mixing the dye with 
1ml 20% F-127 pluronic acid DMSO solution (Invitrogen, Paisley, UK).  All 
stock solutions were kept at room temperature in the dark. 4-(2-(6-
(Dibutylamino-2-naphthalenyethenyl)-1-(3-sulfopropyl)pyridinium 
hydroxide (Di-4-ANEPPS, Cambridge Bioscience, Cambridge, UK) was 
used as a benchmark for comparison against the novel dyes reported here.  
On the day of recording, the stock solution of each dye were diluted to 10-
4 M, unless otherwise stated, in saline and bath applied to the desheathed 
STG for 20 minutes in the dark at 5°C.  After 20 minutes, the dye was 
washed off for a further 20 minutes (2 changes of saline and followed by a 
rest period of 10 minutes at 5°C). 
Intracellular and extracellular recording 
Electrophysiology was performed following Hedrich et al.,[25] whereby the 
STG was pinned and desheathed to facilitate intracellular recording and 
the penetration of the dyes used in this study. For extracellular recordings 
the lvn was isolated from the rest of the preparation bath using petroleum 
jelly to form a well. One of two stainless steel electrodes was inserted into 
this well, while a reference electrode was placed outside of the well in the 
petri dish to create a differential signal between the two electrodes. This 
signal was filtered and amplified with an AC differential amplifier (AM 
Systems Model 1700, Sequim, WA). For intracellular recordings glass 
electrodes (TW120F-3, World Precision Instruments, Aston, Stevenage, 
UK; 25-40 MΩ) were pulled using a P97 puller (Heat: 514, Pull: 130, 
Velocity: 80, Time: 150, P=500; Sutter Instruments, CA, USA) and filled 
with 3M KCl solution.  Signals were amplified using an IE-251A Amplifier 
(Warner Instruments Corporation, Hamden, CT). Both intracellular and 
extracellular signals were recorded and analysed using a Micro 1401-3 
signal processing device (CED, Cambridge, UK) and Spike 2 software 
(CED, Cambridge, UK). 
Intracellular current injection 
For each intracellular neuronal stimulation, 5 sets of 10 x 0.1 nA pulses 
were injected into a selected cell for a duration of 1 second, with a 2 second 
gap between each pulse and a 1 minute gap between each set of pulses.  
Current injections were generated and controlled using Spike2 software 
and a Micro 1401-3 signal processing device (CED, Cambridge, UK).  
During the current injection procedure, fluorescent light was applied and 
the optical activity of each neuron recorded using a MiCAM 02 imaging 
system (SciMedia Ltd., Tokyo, Japan). 
Imaging of fluorescence  
Throughout fluorescence imaging a MiCAM 02 imaging system (SciMedia 
Ltd., Tokyo, Japan) was used along with a high resolution camera (6.4mm 
x 4.8 mm actual sensor chip size).  A 10x objective (UMPLFL10XW, NA 
0.30, WD 3.30 mm, Olympus Corporation, Tokyo, Japan) was mounted on 
a BX51 WI fluorescence microscope (Olympus Corporation, Tokyo, 
Japan).  For the toxicity experiments, the spatial resolution was set at 48 
x 32 pixels and the temporal resolution varied from 1.3 ms to 13.7 ms in 
order to set the desired time for the imaging recording session (starting at 
20s to 300s using increments of 20s light exposure).  At the end of the 
illumination, the light was turned off for a period of time to allow the 
preparation to recover to baseline levels.  During the SNR experiments, 
    
 
 
 
 
 
the spatial resolution was the same as used in the toxicity experiments and 
the temporal resolution was set at 1.5 ms, resulting in a 32 s recording 
period.  Illumination was provided by a 150W ultra-low ripple halogen light 
source (HL-151, Moritex Corporation Tokyo, Japan) with a shutter 
controlled from a computer using BrainVision software (SciMedia Ltd., 
Tokyo, Japan).  For the di-4-ANEPPS experiments a wide green filter cube 
was used (BP 480-550 excitation filter, LP 590 emission filter, Olympus 
Corporation, Tokyo, Japan), while a wide orange filter cube (ET620/60x 
excitation filter, ET700/75m emission filter, Chroma Technology Corp, 
Vermont, USA) was used for the novel dyes presented in this study.  To 
reduce mechanical noise, the microscope was placed on an anti-vibration 
table (630500 series, Technical Manufacturing Corporation, Peabody, MA, 
USA). 
Data analysis and visualisation 
For analysis of the fluorescence imaging data BrainVision software 
(SciMedia Ltd., Tokyo, Japan) was used.  For the calculation of the SNR 
reported the fluorescence data for each of the 5 sets of 10 current 
injections (30 seconds in length) for each cell during the current injection 
(1 sec duration) and between injections (2 sec duration) was averaged 
using Spike2 (CED, Cambridge, UK). Prior to averaging, baseline drifts 
due to thermal changes in the light source and slow frequency components 
of the signal were removed using the DC-remove function in Spike2 (using 
a time constant of 3 secs, CED, Cambridge, UK). The SNR was calculated 
as follows: 
𝑆𝑁𝑅 = ∑
𝜇𝐶𝐼𝑖
𝜎𝜀𝑖
𝑁
𝑖=1        (Eq. 2) 
where i is the index of the i-th neuron, N is the total number of neurons, 
μCIi is the mean of the fluorescence signal during each current injection 
(50 in total) and σεi is the standard deviation of the average fluorescence 
signal considering the periods (50 in total) when no current injection was 
applied to the cell.  The toxicity of each dye was measured by the change 
in the frequency (Hz) of the pyloric rhythm where the length of each pyloric 
cycle was defined as the duration between the onset of an LP neuron burst 
and the onset of the next LP neuron burst. The frequency was calculated 
using custom scripts written in Spike2 (CED, Cambridge, UK). The data 
analysis for the derivation of the linear regression model was done using 
the SPSS software (IBM Corp., Armonk, NY, USA). 
Synthesis 
All chemicals were purchased from commercial sources and used as 
received unless otherwise stated. Basic solvents for synthesis were dried 
using typical literature methods. Solvents for spectroscopic investigations 
were of the highest purity available. The starting material 3,5-dimethyl-8-
julolidyl BODIPY (1) was prepared by using the method previously 
reported by our group.[7e] 
Preparation of 3,5-distyryl-8-julolidyl BODIPY (JULBD1) 
Benzaldehyde (51 L, 0.5 mmol, 4 eq.), piperidine (0.25 mL, 20 eq.) and 
glacial acetic acid (0.14 mL, 20 eq.) were added to a solution of 1 (49 mg, 
0.125 mmol) in anhydrous CH3CN (8 mL) containing 4 Å molecular sieves 
(1 g). The resulting mixture was refluxed until the complete consumption 
of the starting material (1.5 h). The solution was filtered, DCM and Et2O 
(1:5) were added, and the mixture was washed with 0.05 M HCl, saturated 
aqueous NaHCO3 and water. The solvent was removed to give a dark 
purple solid which was washed with hexane and dried under vacuum (50 
mg, 70% yield). 1H NMR (700 MHz, CDCl3): δ (ppm) = 7.80 (d, J = 16.3 
Hz, 2H, trans CH=CH), 7.65 (d, J = 7.5 Hz, 4H, o-Ph), 7.41 (ps t, J = 7.7 
Hz, 4H, m-Ph), 7.34 – 7.28 (m, 4H, trans CH=CH + CH p-Ph), 7.04 (s, 2H, 
PhJul), 6.98 (d, J = 4.3 Hz, 2H, β-pyrrole), 6.93 (d, J = 4.4 Hz, 2H, β-
pyrrole), 3.29 (t, J = 5.7 Hz 4H, CH2 Jul), 2.82 (t, J = 6.3 Hz, 4H, CH2 Jul), 
2.06–1.98 (m, 4H, CH2 Jul). 13C NMR (176 MHz, CDCl3): δ (ppm) = 152.86, 
145.11, 141.85, 136.93, 135.89, 135.21, 130.43, 129.47, 128.89, 128.82, 
127.58, 121.62, 120.89, 119.94, 115.43, 50.11, 27.92, 21.72. 11B NMR (96 
MHz, CDCl3): δ (ppm) = 1.31 (t, J = 33.1 Hz). 19F NMR (282 MHz, CDCl3): 
δ (ppm) = -139.5 (q, J = 33.1 Hz). NSI-FTMS (m/z): found [M]+ 567.2657, 
[M+H]+  568.2711, calcd. for C37H32BF2N3: 567.2652, C37H33BF2N3: 
568.2737. 
Preparation of 3,5-di(4-carboxystyryl)-8-julolidyl BODIPY (JULBD2) 
4-Formylbenzoic acid (112 mg, 0.75 mmol, 6 eq.), piperidine (0.25 mL, 20 
eq.) and glacial acetic acid (0.14 mL, 20 eq.) were added to a solution of 
1 (49 mg, 0.125 mmol) in anhydrous CH3CN (8 mL) containing 4 Å 
molecular sieves (1 g). The resulting mixture was refluxed until the 
complete consumption of the starting material (2 h). MeOH (5 mL) was 
added to fully dissolve the precipitate formed. The solution was filtered, 
DCM and Et2O (1:5) were added and the product extracted with saturated 
aqueous NaHCO3. The combined aqueous layer was acidified with 1 M 
HCl to pH = 6 to give a dark purple solid. The product was recrystallized 
by precipitating from DMSO solution with 0.5 M HCl. The collected solid 
was washed with 0.02 M HCl, water and Et2O and dried under vacuum (45 
mg, 44 % yield). A clear DMSO signal at 2.54 ppm in the 1H-NMR spectrum 
suggests inclusion of two DMSO molecule per BODIPY in the crystalline 
structure. 1H NMR (700 MHz, DMSO-d6): δ (ppm) = 13.01 (s, 2H, CO2H), 
8.02 (d, J = 8.3 Hz, 4H, Ph), 7.74 (d, J = 8.3 Hz, 4H, Ph), 7.69 (br s, 4H, 
CH=CH), 7.30 (d, J = 4.5 Hz, 2H, β-pyrrole), 7.11 (m, 4H, β-pyrrole + 
PhJul), 3.3 –3.33 (overlapped with water peak, 4H, CH2 Jul), 2.79 (t, J = 
6.3 Hz, 4H, CH2 Jul), 1.93 (m, 4H, CH2 Jul). 13C NMR (176 MHz, DMSO-
d6): δ (ppm) = 166.94, 151.06, 145.64, 141.87, 140.38, 134.97, 134.36, 
130.73, 130.43, 130.09, 129.60, 127.00, 120.83, 120.64, 120.07, 116.74, 
49.33, 27.08, 20.87. 11B NMR (96 MHz, DMSO-d6): δ (ppm) = 1.19 (br t, J 
= 30.6 Hz). 19F NMR (282 MHz, CDCl3): δ (ppm) = -136.6 (br q, J = 30.5 
Hz). NSI-FTMS (m/z): found [M–H]– 654.2374, [M–2H]2– 326.6154, calcd. 
for C39H31BF2N3O4: 654.2388, C39H30BF2N3O4: 326.6155. 
Preparation of 3,5-di(4-cyanostyryl)-8-julolidyl BODIPY (JULBD3) 
4-Cyanobenzaldehyde (98 mg, 0.75 mmol, 6 eq.), piperidine (0.25 mL, 20 
eq.) and glacial acetic acid (0.14 mL, 20 eq.) were added to a solution of 
1 (49 mg, 0.125 mmol) in anhydrous CH3CN (8 mL) containing 4 Å 
molecular sieves (1 g). The resulting mixture was refluxed until the 
complete consumption of the starting material (18 h). The solution was 
filtered, DCM and Et2O (1:5) were added, and the mixture was washed 
with 0.05 M HCl, saturated aqueous NaHCO3 and water. The solvent was 
removed to give a black solid which was purified by flash chromatography 
on silica gel (DCM eluent). The solvent was removed to give the desired 
product as a dark purple solid (10 mg, 13 % yield). 1H NMR (700 MHz, 
CDCl3): δ (ppm) = 7.86 (d, J = 16.3 Hz, 2H, trans CH=CH), 7.69 (ps q, J = 
8.4 Hz, 8H, o-Ph + m-Ph), 7.25 (d, J = 16.3 Hz, 2H, trans CH=CH, 
overlapped with CHCl3 peak), 7.06 (s, 2H, PhJul), 7.04 (d, J = 4.3 Hz, 2H, 
β-pyrrole), 6.96 (d, J = 4.4 Hz, 2H, β-pyrrole), 3.36 – 3.29 (m, 4H, CH2 Jul), 
2.82 (t, J = 6.2 Hz, 4H, CH2 Jul), 2.07–1.99 (m, 4H, CH2 Jul). 13C NMR 
(176 MHz, CDCl3): δ (ppm) = 151.59, 145.71, 143.34, 141.23, 136.36, 
132.70, 132.68, 130.76, 129.93, 127.75, 123.09, 121.31, 121.05, 119.09, 
116.06, 111.57, 50.15, 27.94, 21.61. 11B NMR (96 MHz, CDCl3): δ (ppm) 
= 1.24 (t, J = 33.2 Hz). 19F NMR (282 MHz, CDCl3): δ (ppm) = -138.6 (q, J 
= 33.3 Hz). NSI-FTMS (m/z): found [M]+ 617.2547, [M+H]+  618.2618, 
calcd. for C39H30BF2N5: 617.2564, C39H31BF2N5: 618.2642. 
 
    
 
 
 
 
 
Preparation of 3,5-di(4-nitrostyryl)-8-julolidyl BODIPY (JULBD4) 
4-Nitrobenzaldehyde (113 mg, 0.75 mmol, 6 eq.), piperidine (0.25 mL, 20 
eq.) and glacial acetic acid (0.14 mL, 20 eq.) were added to a solution of 
1 (49 mg, 0.125 mmol) in anhydrous CH3CN (8 mL) containing 4 Å 
molecular sieves (1 g). The resulting mixture was refluxed until the 
complete consumption of the starting material (18 h). The solution was 
filtered, DCM and Et2O (1:5) were added, and the mixture was washed 
with 0.05 M HCl, saturated aqueous NaHCO3 and water. The solvent was 
removed to give a black solid which was purified by flash chromatography 
on silica gel (DCM/Petrol 1/1 eluent). The solvent was removed to give the 
desired product as a dark purple solid (8 mg, 10 % yield). 1H NMR (700 
MHz, CDCl3): δ (ppm) = 8.26 (d, J = 8.6 Hz, 4H, Ph), 7.92 (d, J = 16.4 Hz, 
2H, trans CH=CH), 7.75 (d, J = 8.6 Hz, 4H, Ph), 7.30 (d, J = 16.4 Hz, 2H, 
trans CH=CH), 7.08 (s, 2H, PhJul), 7.05 (d, J = 4.3 Hz, 2H, β-pyrrole), 6.98 
(d, J = 4.4 Hz, 2H, β-pyrrole), 3.37–3.31 (m, 4H, CH2 Jul), 2.83 (t, J = 6.2 
Hz, 4H, CH2 Jul), 2.03–2.06 (m, 4H, CH2 Jul). 13C NMR (176 MHz, CDCl3): 
δ (ppm) = 151.74, 147.68, 145.91, 143.80, 143.30, 136.69, 132.29, 130.87, 
130.07, 127.86, 124.40, 124.10, 121.52, 121.22, 116.28, 50.28, 28.02, 
21.75. 11B NMR (96 MHz, CDCl3): δ (ppm) = 1.25 (t, J = 33.2 Hz). 19F 
NMR (282 MHz, CDCl3): δ (ppm) = -138.3 (q, J = 33.1 Hz). NSI-FTMS 
(m/z): found [M]+ 657.2339, [M+H]+  658.2418, calcd. for C37H30BF2N5O4: 
657.2360, C37H31BF2N5O4: 658.2438. 
Preparation of 3,5-di(4-vinylpyridinyl)-8-julolidyl BODIPY (JULBD5) 
4-Pyridinecarboxaldehyde (40.2 mg, 0.375 mmol, 3 eq.), piperidine (0.25 
mL, 20 eq.) and glacial acetic acid (0.14 mL, 20 eq.) were added to a 
solution of 1 (49 mg, 0.125 mmol) in anhydrous CH3CN (8 mL) containing 
4 Å molecular sieves (1 g). The resulting mixture was refluxed until the 
complete consumption of the starting material (4 h). Solvent was removed 
and solid redissolved in DCM, filtered on silica gel with DCM to remove the 
starting material and extracted with 5 % MeOH in DCM to give the final 
product in 50 mg yield (~ 90 % purity). Further purification by flash 
chromatography on silica gel (4 % MeOH in DCM eluent) gave the desired 
product as a dark blue solid (35 mg, 49 % yield). 1H NMR (700 MHz, 
CDCl3): δ (ppm) = 8.65–8.63 (m, 4H, Py), 7.95 (d, J = 16.3 Hz, 2H, trans 
CH=CH), 7.48 – 7.47 (m, 4H, Py), 7.18 (d, J = 16.3 Hz, 2H, trans CH=CH), 
7.07 (s, 2H, PhJul), 7.04 (d, J = 4.3 Hz, 2H, β-pyrrole), 6.97 (d, J = 4.4 Hz, 
2H, β-pyrrole), 3.34–3.31 (m, 4H, CH2 Jul), 2.82 (t, J = 6.3 Hz, 4H, CH2 
Jul), 2.07–1.99 (m, 4H, CH2 Jul). 13C NMR (176 MHz, CDCl3): δ (ppm) = 
151.31, 150.34, 145.62, 143.81, 143.62, 136.15, 131.87, 130.66, 129.83, 
123.75, 121.25, 121.16, 120.90, 116.01, 50.01, 27.79, 21.45. 11B NMR (96 
MHz, CDCl3): δ (ppm) = 1.22 (t, J = 33.0 Hz). 19F NMR (282 MHz, CDCl3): 
δ (ppm) = -138.5 (q, J = 33.2 Hz). NSI-FTMS (m/z): found [M+H]+  
570.2628, calcd. for C35H31BF2N5: 570.2641. 
Preparation of 3,5-di(N-methyl-4-vinylpyridinium)-8-julolidyl BODIPY 
di(hexafluorophosphate) (JULBD6) 
MeI (1 mL) was added to a solution of JULBD5 (17 mg, 0.03 mmol) in 
CH3CN (6 mL) and the mixture stirred at RT for 16 h. Addition of Et2O 
resulted in precipitation of the target compound. The product was 
recrystallized three times from DMF by addition of saturated aq. KPF6 and 
three times by precipitating with Et2O from DMF. The solid was washed 
with Et2O and dried to yield the target compound as a dark blue solid (20 
mg, 75 % yield). 1H NMR (700 MHz, DMSO-d6): δ (ppm) =  8.86 (d, J = 6.3 
Hz, 4H, Py), 8.17 (d, J = 6.3 Hz, 4H, Py), 8.01 (d, J = 16.2 Hz, 2H, trans 
CH=CH), 7.79 (d, J = 16.2 Hz, 2H, trans CH=CH), 7.42 (d, J = 4.2 Hz, 2H, 
β-pyrrole), 7.26 (d, J = 4.1 Hz, 2H, β-pyrrole), 7.23 (s, 2H, PhJul), 4.30 (s, 
6H, CH3), 3.45–3.37 (m, 4H, CH2 Jul), 2.81 (t, J = 5.6 Hz, 4H, CH2 Jul), 
1.99–1.87 (m, 4H, CH2 Jul). 13C NMR (176 MHz, DMSO-d6): δ (ppm) = 
151.37, 148.87, 147.65, 145.87, 144.33, 136.61, 132.06, 130.52, 129.40, 
128.85, 124.34, 122.07, 120.98, 118.98, 50.08, 47.64, 27.47, 21.08. 11B 
NMR (96 MHz, DMSO-d6): δ (ppm) =  1.09 (t, J = 32.5 Hz). 19F NMR (659 
MHz, DMSO-d6): δ (ppm) = -70.1 (d, J = 711.3 Hz, 12F, PF6), -135.0 (q, J 
= 32.6 Hz, 2F, BF2). NSI-FTMS (m/z): found [M–PF6]+ 744.2663, [M–
2PF6]2+ 299.6513, calcd. for C37H36BF8N5P: 744.2669, C37H36BF2N5: 
299.6514. 
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